We are live on
!
Find out more
RC
Roubaix Capital Portfolio holdings
AUM
$214M
1-Year Est. Return
32.43%
This Fund
S&P 500
This Quarter
Est. Return
+6.24%
1 Year Est. Return
+32.43%
3 Year Est. Return
+104.01%
5 Year Est. Return
+128.11%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$18.8M
(+19%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
12.33%
Top 10 Holdings %
Top 10 Hldgs %
45.73%
Holding
55
New
17
Increased
13
Reduced
3
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parsons
PSN
|
+$6.05M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$5.77M |
| 3 |
Americold
COLD
|
+$5.17M |
| 4 |
Transmedics
TMDX
|
+$4.67M |
| 5 |
ATSG
Air Transport Services Group
ATSG
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merit Medical Systems
MMSI
|
+$4.35M |
| 2 |
Methode Electronics
MEI
|
+$3.85M |
| 3 |
Albany International
AIN
|
+$3.78M |
| 4 |
SRCL
Stericycle Inc
SRCL
|
+$3.68M |
| 5 |
Clarus
CLAR
|
+$3.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Healthcare | 22.29% |
| 3 | Industrials | 17.78% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
STAAR Surgical
STAA
$1.19B
| $2.56M | 2.13% |
+87,004
| New | +$2.51M |
|
27
BioLife Solutions
BLFS
$1.54B
| $2.04M | 1.7% |
120,313
+75,068
| +166% | +$1.31M |
|
28
Rogers Corp
ROG
$2.09B
| $2M | 1.67% |
11,605
-11,979
| -51% | -$1.95M |
|
29
Moelis & Co
MC
$4.85B
| $1.99M | 1.66% |
56,958
-21,842
| -28% | -$790K |
|
30
MGP Ingredients
MGPI
$404M
| $1.99M | 1.66% |
+30,006
| New | +$2.11M |
|
31
Webster Financial
WBS
$12.3B
| $1.98M | 1.65% |
41,468
+17,260
| +71% | +$860K |
|
32
Mayville Engineering Co
MEC
$648M
| $1.88M | 1.57% |
+136,332
| New | +$2.1M |
|
|
CEMI
33
DELISTED
Chembio diagnostics, Inc.
CEMI
| $990K | 0.83% |
+162,500
| New | +$1.1M |
|
34
Addus HomeCare
ADUS
$2.22B
| – | – |
-47,121
| Closed | -$3M |
|
|
35
Albany International
AIN
$2.09B
| – | – |
-52,859
| Closed | -$3.78M |
|
36
Amalgamated Financial
AMAL
$1.47B
| – | – |
-55,171
| Closed | -$863K |
|
37
ATI
ATI
$24.3B
| – | – |
-104,912
| Closed | -$2.68M |
|
38
Astronics
ATRO
$3.21B
| – | – |
-98,496
| Closed | -$2.69M |
|
39
Azenta
AZTA
$1.3B
| – | – |
-80,027
| Closed | -$2.35M |
|
40
Cass Information Systems
CASS
$716M
| – | – |
-32,913
| Closed | -$1.56M |
|
41
CEVA Inc
CEVA
$831M
| – | – |
-107,085
| Closed | -$2.89M |
|
|
42
Clarus
CLAR
$125M
| – | – |
-254,050
| Closed | -$3.24M |
|
43
CryoPort
CYRX
$753M
| – | – |
-129,932
| Closed | -$1.68M |
|
44
EnerSys
ENS
$6.43B
| – | – |
-37,531
| Closed | -$2.45M |
|
45
Kirby Corp
KEX
$7.01B
| – | – |
-24,872
| Closed | -$1.87M |
|
|
46
Methode Electronics
MEI
$458M
| – | – |
-133,864
| Closed | -$3.85M |
|
|
47
Merit Medical Systems
MMSI
$4.82B
| – | – |
-70,388
| Closed | -$4.35M |
|
48
Watsco Inc
WSO
$13.2B
| – | – |
-16,325
| Closed | -$2.34M |
|
|
CDMO
49
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-488,600
| Closed | -$2.08M |
|
|
SRCL
50
DELISTED
Stericycle Inc
SRCL
| – | – |
-67,626
| Closed | -$3.68M |
|
Similar funds
GC
TSS
CMBA
VCM
IH
IAM
VFG
CCM
Roubaix Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Roubaix Capital held 55 positions worth $120M, up 19% from $101M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Roubaix Capital deployed $14.8M of net new capital in Q2 2019, opening 17 new positions and adding to 13 existing holdings. Its largest new stake was Parsons: 184,625 shares worth $6.8M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Rogers Corp, an estimated $1.95M trimmed.
- Roubaix Capital's largest Q2 2019 buy was Parsons: 184,625 shares worth $6.8M.
- Roubaix Capital added most to Park Aerospace in Q2 2019, an estimated $3.05M increase.
- Roubaix Capital's biggest Q2 2019 reduction was Rogers Corp, cutting an estimated $1.95M.
- Roubaix Capital fully exited Merit Medical Systems in Q2 2019, selling an estimated $4.35M.
- Roubaix Capital's ten largest holdings make up 46% of its $120M portfolio in Q2 2019.
- Roubaix Capital opened 17 new positions and closed 22 in Q2 2019.
- Roubaix Capital's portfolio value rose 19% quarter-over-quarter to $120M.
Based on Roubaix Capital's 13F filing for Q2 2019, filed 30 Jul 2019.